Lataa...
Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders
BACKGROUND: Lubiprostone is a ClC-2 chloride channel activator approved for the treatment of chronic idiopathic constipation (CIC) and opioid-induced constipation (OIC) in adults and irritable bowel syndrome with constipation (IBS-C) in women. Lubiprostone is generally well tolerated, with nausea be...
Tallennettuna:
| Julkaisussa: | Dig Dis Sci |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer US
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694526/ https://ncbi.nlm.nih.gov/pubmed/28849329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-017-4680-1 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|